净水技术2024，Vol.43Issue(z1)：204-209,264,7.DOI:10.15890/j.cnki.jsjs.2024.s1.030
UHASB升流式水解酸化反应器处理制药废水的中试试验
Pilot Study on UHASB Upflow Hydrolysis Acidification Reactor for Pharmaceutical Waste water Treatment
甘致溪 1刘芷辰 2白鹏 3崔祁嘉 1程珣 1严博文4
作者信息
- 1. 成都环境创新科技有限公司,四川成都 610000
- 2. 成都环投新能源产业发展有限公司,四川成都 610000
- 3. 成都环投新能源产业发展有限公司,四川成都 610000||成都环境投资集团有限公司,四川成都 610000
- 4. 石家庄兴蓉环境发展有限责任公司,河北石家庄 050000
- 折叠
摘要
Abstract
For the issue of poor operational performance of the hydrolysis acidification tank in the industrial wastewater treatment plants(WWTPs)with pharmaceutical wastewater as the main source,caused by uneven water distribution,sludge compaction,and short flow.A pilot-scale test was conducted on the industrial wastewater which mostly consisted in pharmaceutical wastewater,using an upflow hydrolysis acidification reactor-UHASB.The result of field test showed that when the CODCr concentration of influent water was 195.4～600 mg/L,the average CODCr removal rates of two pilot-scale devices above 31.51％,and the average SCODCr/CODCr ratios above 0.80,compared to the control group,the CODCr removal rate was increased by more than 15％,and the average SCODCr/CODCr ratio was improved by over 33％;When the influent water was affected by quality or quantity shocks,the CODCr concentration of outlet water in the pilot-scale devices remain stably at around 200 mg/L,with the CODCr fluctuation inhibition rate exceeding 60％.The research results indicate that the UHASB upflow hydrolysis acidification reactor has significant advantages in treating wastewater from the WWTP compared to the existing pre-treatment processes.The pilot study provides technical reference for the renovation of the industrial waste water treatment plants.关键词
升流式水解酸化反应器/工业废水/SCODCr/耐冲击/有机物断链Key words
upflow hydrolytic acidification reactor/industrial wastewater/SCODCr/impact resistance/organic molecule chain breakage分类
环境科学引用本文复制引用
甘致溪,刘芷辰,白鹏,崔祁嘉,程珣,严博文..UHASB升流式水解酸化反应器处理制药废水的中试试验[J].净水技术,2024,43(z1):204-209,264,7.
